
More Rigorous Data Needed to Determine Success of SDOH Intervention Programs
In a recent webinar in collaboration with the National Pharmaceutical Council, experts discussed how to evaluate SDOH programs and interventions from a cost perspective. Speakers emphasized the incomplete state of current knowledge and the need to improve studies and data infrastructure to determine their value.